Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nutex Health (NUTX) Receivables (2016 - 2025)

Historic Receivables for Nutex Health (NUTX) over the last 17 years, with Q3 2025 value amounting to $7.3 million.

  • Nutex Health's Receivables fell 8836.57% to $7.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $7.3 million, marking a year-over-year decrease of 8836.57%. This contributed to the annual value of $232.4 million for FY2024, which is 29650.62% up from last year.
  • As of Q3 2025, Nutex Health's Receivables stood at $7.3 million, which was down 8836.57% from $5.7 million recorded in Q2 2025.
  • In the past 5 years, Nutex Health's Receivables registered a high of $295.1 million during Q1 2025, and its lowest value of $334958.0 during Q2 2021.
  • Over the past 5 years, Nutex Health's median Receivables value was $58.3 million (recorded in 2022), while the average stood at $67.3 million.
  • As far as peak fluctuations go, Nutex Health's Receivables soared by 62372908.17% in 2021, and later crashed by 9060.32% in 2025.
  • Over the past 5 years, Nutex Health's Receivables (Quarter) stood at $114.1 million in 2021, then tumbled by 48.85% to $58.3 million in 2022, then increased by 0.49% to $58.6 million in 2023, then skyrocketed by 296.51% to $232.4 million in 2024, then plummeted by 96.86% to $7.3 million in 2025.
  • Its last three reported values are $7.3 million in Q3 2025, $5.7 million for Q2 2025, and $295.1 million during Q1 2025.